K H Tam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
K H Tam has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bernice Shinyi Chan
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong , 5/F, Academic Building, No.3 Sassoon Road, Pokfulam, Hong Kong SAR
1 shared publication - Chun-Ka Wong
Cardiology Division, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; Cardiology Division, Department of Medicine, Queen Mary Hospital, Hong Kong
1 shared publication - Doris Sau Fung Yu
The University of Hong Kong, Hong Kong, Hong Kong
1 shared publication - Polly Wai Chi Li
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong , 5/F, 3 Sassoon Road, Pokfulam
1 shared publication
Latest Publications
- Open Access
- 1 August 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
Estimated global prevalence of metabolic syndrome: a proportional meta-analysis
Aims: Metabolic syndrome is a major global health burden. However, existing global prevalence estimates are largely based on studies conducted before the COVID-19 pandemic and do not fully account for contemporary epidemiological and structural determinants. This systematic review and meta-analysis updated global metabolic syndrome prevalence estimates and examined associated socioeconomic and healthcare system correlates using the most recent available evidence. Methods and results: Six databases were searched from inception to 27 October 2025, for studies reporting crude metabolic syndrome prevalence among adults. Two reviewers independently screened the studies and extracted data. Random-effects proportional meta-analyses and meta-regression were performed to estimate the prevalence of metabolic syndrome and explore associated determinants, respectively. A total of 684 unique observational studies involving 44 979 527 participants were included in quantitative data synthesis. The global metabolic syndrome prevalence ranged from 19% (95% CI: 15–24%) to 31% (95% CI: 30–33%), with substantial heterogeneity across analyses. Subgroup analysis according to World Bank region indicated that studies conducted in South Asia (range: 30–35%) and Latin America and the Caribbean (range: 33–55%) reported higher prevalence rates than studies in other regions. Higher metabolic syndrome prevalence was significantly associated with an older age, higher proportion of females, greater income inequality, and higher Universal Health Coverage. Pre- and post-pandemic subgroup analyses showed no statistically significant difference in prevalence overall. Conclusion: Metabolic syndrome remains a substantial global health challenge in the post-pandemic era. Beyond estimating prevalence, this review suggests that structural socioeconomic factors and health system coverage are meaningfully associated with prevalence patterns, supporting targeted prevention strategies in socioeconomically disadvantaged regions and populations. Registration: PROSPERO: CRD42024594179
- 1 August 2026
- Published by Oxford University Press (OUP) in European Journal of Cardiovascular Nursing
Open AccessEstimated global prevalence of metabolic syndrome: a proportional meta-analysis
Aims: Metabolic syndrome is a major global health burden. However, existing global prevalence estimates are largely based on studies conducted before the COVID-19 pandemic and do not fully account for contemporary epidemiological and structural determinants. This systematic review and meta-analysis updated global metabolic syndrome prevalence estimates and examined associated socioeconomic and healthcare system correlates using the most recent available evidence. Methods and results: Six databases were searched from inception to 27 October 2025, for studies reporting crude metabolic syndrome prevalence among adults. Two reviewers independently screened the studies and extracted data. Random-effects proportional meta-analyses and meta-regression were performed to estimate the prevalence of metabolic syndrome and explore associated determinants, respectively. A total of 684 unique observational studies involving 44 979 527 participants were included in quantitative data synthesis. The global metabolic syndrome prevalence ranged from 19% (95% CI: 15–24%) to 31% (95% CI: 30–33%), with substantial heterogeneity across analyses. Subgroup analysis according to World Bank region indicated that studies conducted in South Asia (range: 30–35%) and Latin America and the Caribbean (range: 33–55%) reported higher prevalence rates than studies in other regions. Higher metabolic syndrome prevalence was significantly associated with an older age, higher proportion of females, greater income inequality, and higher Universal Health Coverage. Pre- and post-pandemic subgroup analyses showed no statistically significant difference in prevalence overall. Conclusion: Metabolic syndrome remains a substantial global health challenge in the post-pandemic era. Beyond estimating prevalence, this review suggests that structural socioeconomic factors and health system coverage are meaningfully associated with prevalence patterns, supporting targeted prevention strategies in socioeconomically disadvantaged regions and populations. Registration: PROSPERO: CRD42024594179